AYTU BIOPHARMA, INC Interest Payable, Current
AYTU BIOPHARMA, INC (AYTU) had Interest Payable, Current of $18.54 thousand as of 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2015-04-15
- 2015-02-28: Interest Payable, Current $18.54K.
- 2014-11-30: Interest Payable, Current $18.07K.
- 2014-05-31: Interest Payable, Current $17.20K.
- 2014-02-28: Interest Payable, Current $9.49K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2015-02-28 | $18.54K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $18.07K 10-Q · filed 2015-01-12 | |
| 2014-05-31 | $17.20K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $9.49K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $9.49K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $13.37K 10-K · filed 2014-11-26 | |
| 2012-09-30 | $11.91K 10-Q · filed 2013-06-28 | $9.49K 10-Q · filed 2013-01-14 |
| 2012-08-31 | $8.47K 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |